Patients bearing germline and/or somatic mutations of CD95—or in fewer cases of CD95L—can indeed develop Autoimmune Lympho-Proliferative Syndromes (ALPS) [98]. The gene discussed is FASLG; the disease is autoimmune lymphoproliferative syndrome.